Any metabolite (endogenous or exogenous) found in human urine samples.
| Member | Definition | Class |
|---|
| (3,4-dimethoxyphenyl)acetic acid | A phenylacetic acid substituted at positions 3 and 4 by methoxy groups. | homoveratric acid |
| 1-hydroxymethylmidazolam | An imidazobenzodiazepine that is midazolam in which one of the hydrogens of the methyl group is substituted by a hydroxy group. It is the major metabolite of the anesthetic, midazolam. | 1-hydroxymidazolam |
| 1-hydroxymethylmidazolam glucuronide | A beta-D-glucosiduronic acid that is beta-D-glucuronic acid in which the anomeric hydroxyl hydrogen has been replaced by a 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-4-yl group. It is the glucuronidated conjugate of the midazolam metabolite, 1-hydroxymidazolam. | 1-hydroxymidazolam beta-D-glucuronide |
| 1-methylhypoxanthine | A methylhypoxanthine that is hypoxanthine with the methyl group at position 1. | 1-methylhypoxanthine |
| 1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid | A member of the class of beta-carbolines that is 1,2,3,4-tetrahydro-beta-carboline substituted at position 3 by a carboxy group. | 1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid |
| 1,2,4-triazole-3-carboxamide | A member of the class of triazoles that is 1H-1,2,4-triazole substituted by an aminocarbonyl group at position 3. It is the major catabolite and aglycon of ribavirin. | 1,2,4-triazole-3-carboxamide |
| 1,3,7-trimethylurate | An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8, and the nitrogens at positions 1, 3, and 7 are substituted by methyl groups. It is a metabolite of caffeine. | 1,3,7-trimethyluric acid |
| 2-(methylamino)isobutyric acid | A non-proteinogenic alpha-amino acid that is isobutyric acid in which the alpha-hydrogen has been replaced by a methylamino group. | alpha-(methylamino)isobutyric acid; N-methyl-aminoisobutyrate zwitterion |
| 2-methylfuran | A member of the class of furans that is furan in which the hydrogen at position 2 is replaced by a methyl group. | 2-methylfuran |
| 2-naphthol | A naphthol carrying a hydroxy group at position 2. | 2-naphthol |
| 2-pentylfuran | A member of the class of furans that is furan in which the hydrogen at position 2 is replaced by a pentyl group. It is found in many heat-processed foods and drinks. | 2-pentylfuran |
| 2-s-cysteinyldopa | An L-tyrosine derivative that is L-DOPA in which the hydrogen at position 2 on the phenyl ring is replaced by a cysteinyl group. Found in the urine of patients with melanoma. | 2-S-cysteinyl-DOPA |
| 2,3,4-trihydroxbenzophenone | A benzenetriol that is benzophenone in which one of the phenyl groups is substituted by hydroxy groups at positions 2, 3, and 4. It is a redox mediator. | 2,3,4-trihydroxbenzophenone |
| 2,5-dimethylfuran | A member of the class of furans that is furan in which the hydrogens at positions 2 and 5 are replaced by methyl groups. | 2,5-dimethylfuran |
| 2,5-furandicarboxylic acid | A member of the class of furans carrying two carboxy substituents at positions 2 and 5. | furan-2,5-dicarboxylic acid |
| 2,8-dihydroxyadenine | An oxopurine that is adenine bearing two oxo substituents at positions 2 and 8. | 2,8-dihydroxyadenine; 2,8-dioxoadenine |
| 2,8-dihydroxyadenine | A member of the class of 6-aminopurines that is adenine bearing two hydroxy substituents at positions 2 and 8. It is a highly insoluble metabolite of adenine that causes radiolucent urolithiasis. It is produced by individuals who suffer from adenine phosphoribosyltransferase (APRT) deficiency, a rare autosomal recessive error of purine metabolism. | 2,8-dihydroxyadenine; 2,8-dioxoadenine |
| 20-carboxyleukotriene b4 | A member of the class of leukotrienes that is leukotriene B4 in which the terminal methyl group has undergone formal oxidation to the corresponding carboxylic acid. | 20-hydroxy-20-oxoleukotriene B4 |
| 3 alpha,17 alpha-dihydroxy-5 beta-pregnan-20-one | A 17alpha-hydroxy steroid that is 3alpha-hydroxy-5beta-pregnan-20-one carrying an additional hydroxy group at position 17alpha. | 3alpha,17alpha-dihydroxy-5beta-pregnan-20-one |
| 3-(1H-imidazol-1-yl)propanoic acid | An imidazolyl carboxylic acid that is propanoic acid in which one of the methyl hydrogens is substituted by an imidazol-1-yl group. It is a metabolite of histidine found in human urine and faeces. | 3-(1H-imidazol-1-yl)propanoic acid |
| 3-(3-hydroxyphenyl)-3-hydroxypropanoic acid | A dihydroxy monocarboxylic acid that is 3-hydroxypropanoic acid substituted by a 3-hydroxyphenyl group at position 3. | 3-(3-hydroxyphenyl)-3-hydroxypropanoic acid |
| 3-hydroxyglutaric acid | A 3 hydroxy carboxylic acid that is glutaric acid which is substituted by a hydroxy group at position 3. It is a diagnostic marker for glutaric aciduria type I. | 3-hydroxyglutaric acid |
| 3-hydroxymethylantipyrine | A pyrazolone that is antipyrine in which one of the hydrogens of the 5-methyl group is substituted by a hydroxymethyl group. It is a metabolite of the analgesic drug, antipyrene. | 3-hydroxymethylantipyrine |
| 3-methoxybenzoic acid | A methoxybenzoic acid that is benzoic acid substituted by a methoxy group at position 3. | 3-methoxybenzoic acid |
| 3-methoxytyramine | A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas. | 3-methoxytyramine |
| 3-methyladipic acid | An alpha,omega-dicarboxylic acid that is adipic acid substituted with a methyl group at position C-3. | 3-methyladipic acid |
| 3-octanone | A dialkyl ketone that is octane in which the two methylene protons at position 3 have been replaced by an oxo group. | 3-octanone |
| 3-tyramine | A primary amino compound that is 2-phenylethanamine substituted by a hydroxy group at position 3. | m-tyramine |
| 3,4,5-trimethoxybenzoic acid | A benzoic acid derivative carrying 3-, 4- and 5-methoxy substituents. | 3,4,5-trimethoxybenzoic acid |
| 3,5,6-trichloro-2-pyridinol | A hydroxypyridine that is pyridin-2-ol substituted by chloro groups at positions 3,5 and 6. It is a metabolite of the agrochemical chlorpyrifos. | 3,5,6-trichloro-2-pyridinol; 3,5,6-trichloropyridine-2-one |
| 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol | A member of the class of nitrosamines that is butan-1-ol substituted by a pyridin-3-yl group at position 1 and by a methyl(nitroso)amino group at position 4. It is a major metabolite of nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), which is a carcinogen found in tobacco and responsible for inducing lung cancer in smokers. | 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol |
| 4-anisaldehyde | A member of the class of benzaldehydes consisting of benzaldehyde itself carrying a methoxy substituent at position 4. | p-methoxybenzaldehyde |
| 4-bromophenol | A bromophenol containing only hydroxy and bromo substituents that are para to one another. | 4-bromophenol |
| 4-cymene | A monoterpene that is toluene substituted by an isopropyl group at position 4. | p-cymene |
| 4-heptanone | A dialkyl ketone that is heptane in which the two methylene protons at position 4 have been replaced by an oxo group. | 4-heptanone |
| 4-hydroxyestrone | A 4-hydroxy steroid that is estrone substituted by a hydroxy group at position 4. | 4-hydroxyestrone |
| 4-hydroxymidazolam | An imidazobenzodiazepine that is midazolam which is substituted by a hydroxy group at position 4. It is the minor hydroxylated metabolite of the anesthetic, midazolam. | 4-hydroxymidazolam |
| 4-vinylphenol | A member of the class of phenols that is styrene carrying a hydroxy substituent at position 4. | 4-hydroxystyrene |
| 5-hydroxyhexanoic acid | A medium-chain fatty acid that is hexanoic acid substituted at position 5 by a hydroxy group. | 5-hydroxyhexanoic acid |
| 5-hydroxymethyl-2-furoic acid | A member of the class of furoic acids that is 2-furoic acid substituted at position 5 by a hydroxymethyl group. | 5-hydroxymethyl-2-furoic acid |
| 5-methoxyindoleacetic acid | A member of the class of indole-3-acetic acids in which the hydrogen at position 5 of indole-3-acetic acid has been replaced by a methoxy group. | 5-methoxyindole-3-acetic acid |
| 5-methoxysalicylic acid | A methoxysalicylic acid that is salicylic acid which is carrying a methoxy group at position 5. | 5-methoxysalicylic acid |
| 5,12-dihydroxy-6,8,14-eicosatrienoic acid | A leukotriene obtained by formal dehydrogenation of the 10,11-double bond in leukotriene B4. | 10,11-dihydroleukotriene B4 |
| 6-hydroxynicotinic acid | A monohydroxypyridine that is the 6-hydroxy derivative of nicotinic acid. | 6-hydroxynicotinic acid |
| acetaminophen mercapturate | An S-substituted N-acetyl-L-cysteine in which the S-substitutuent is specified as 5-acetamido-2-hydroxyphenyl. | S-(5-acetamido-2-hydroxyphenyl)-N-acetyl-L-cysteine |
| acetyltaurine | An amino sulfonic acid that is taurine substituted by an acetyl group at the N atom. | acetyltaurine |
| adrenosterone | A 3-oxo Delta(4)-steroid that is androst-4-ene carrying three oxo-substituents at positions 3, 11 and 17. | adrenosterone |
| alpha-ketoadipic acid | An oxo dicarboxylic acid that is adipic acid substituted by an oxo group at position 2. | 2-oxoadipic acid |
| androsterone | An androstanoid that is 5alpha-androstane having a hydroxy substituent at the 3alpha-position and an oxo group at the 17-position. It is a metabolite of dehydroepiandrosterone . | androsterone |
| arsenocholine | An arsonium ion that is choline in which the central nitrogen has been replaced by arsenic. | arsenocholine |
| bay-s 9435 | An organosulfonic acid that is ciprofloxacin carrying a sulfo group at position 4 of the piperazine ring. It is a metabolite of ciprofloxacin. | sulfociprofloxacin |
| benzohydrol | A secondary alcohol that is diphenylmethane which carries a hydroxy group at position 1. | diphenylmethanol |
| bradykinin, hydroxy-pro(3)- | An oligopeptide that is an analogue of bradykinin in which the third amino acid, proline, is replaced with hydroxyproline. | [Hyp(3)]-bradykinin |
| butyric acid | A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group. | butyric acid |
| cedrene | A sesquiterpene that is cedrane which has a double bond between positions 8 and 9. | cedr-8-ene |
| cystathionine ketimine | A 1-thia-4-azacyclohepta-3-ene-3,5-dicarboxylic acid that has R-configuration. It is cyclic sulfur-containing imino acid detected in bovine brain extracts. | cystathionine ketimine |
| decanoylcarnitine | An O-acylcarnitine compound having decanoyl as the acyl substituent. | O-decanoylcarnitine |
| dihydrotestosterone glucuronide | A steroid glucosiduronic acid that is 5alpha-dihydrotestosterone having a single beta-D-glucuronic acid residue attached at position 17. | 5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide) |
| dopamine 3-o-sulfate | An aryl sulfate that is dopamine in which the phenolic hydrogen at position 3 has been replaced by a sulfo group. | dopamine 3-O-sulfate zwitterion; dopamine 3-O-sulfate |
| dopamine 3-o-sulfate | A zwitterion obtained by transfer of a proton from the sulfonyl to the amino group of dopamine 3-O-sulfate; major species at pH 7.3. | dopamine 3-O-sulfate zwitterion; dopamine 3-O-sulfate |
| dopamine 4-o-sulfate | An aryl sulfate that is dopamine in which the phenolic hydrogen at position 4 has been replaced by a sulfo group. | dopamine 4-O-sulfate zwitterion; dopamine 4-O-sulfate |
| dopamine 4-o-sulfate | A zwitterion obtained by transfer of a proton from the sulfonyl to the amino group of dopamine 4-O-sulfate; major species at pH 7.3. | dopamine 4-O-sulfate zwitterion; dopamine 4-O-sulfate |
| estradiol 17-sulfate | A steroid sulfate obtained by the formal condensation of sulfuric acid with the 17-hydroxy group of 17beta-estradiol. | 17beta-estradiol 17-sulfate |
| estriol-16 alpha-glucuronide | A steroid glucosiduronic acid that is estriol in which the phenolic hydrogen has been replaced by a beta-D-glucuronyl residue. | estriol 16-O-(beta-D-glucuronide) |
| ethyl glucuronide | A beta-D-glucosiduronic acid that is the ethyl derivative of beta-D-glucuronic acid. | ethyl glucuronide |
| gamma-glutamylphenylalanine | A dipeptide obtained by formal condensation of the side-chain carboxy group of L-glutamic acid with the amino group of L-phenylalanine. | gamma-Glu-Phe |
| genistein | A 7-hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties. | genistein |
| hawkinsin | A cysteine derivative that is cysteine in which the thiol group is substituted by a [2-(carboxymethyl)-2,5-dihydroxycyclohex-3-en-1-yl]sulfanediyl group. Hawkinsinuria is an inherited disorder which is characterized by the inability to break down the amino acid tyrosine. This results in the finding of certain metabolites in the urine, such as hawkinsin. | hawkinsin |
| kaempferol | A tetrahydroxyflavone in which the four hydroxy groups are located at positions 3, 5, 7 and 4'. Acting as an antioxidant by reducing oxidative stress, it is currently under consideration as a possible cancer treatment. | kaempferol |
| lanthionine ketimine | A member of the class of 1,4-thiazines that is 3,6-dihydro-2H-1,4-thiazine substituted by carboxy groups at positions 3 and 5. It is a natural but non-proteogenic amino acid found in human urine and brain. | lanthionine ketimine |
| methyl 2,5-dihydroxycinnamate | A cinnamate ester that is the methyl ester of 2,5-dihydroxycinnamic acid. | 2,5-dihydroxycinnamic acid methyl ester |
| mono(2-ethyl-5-hydroxyhexyl) phthalate | A phthalic acid monoester obtained by formal condensation of one of the carboxy groups of phthalic acid with the primary hydroxy group of 2-ethylhexane-1,5-diol | mono(2-ethyl-5-hydroxyhexyl) phthalate |
| mono(2-ethyl-5-oxohexyl)phthalate | A phthalic acid monoester obtained by formal condensation of one of the carboxy groups of phthalic acid with the hydroxy group of 2-ethyl-5-oxohexan-1-ol. | mono(2-ethyl-5-oxohexyl) phthalate |
| n-acetyldopamine | A secondary carboxamide obtained by formal condensation of the carboxy group of acetic acid with the amino group of dopamine. A dopamine metabolite. | N-acetyldopamine |
| n-acetylleukotriene e4 | A leukotriene that is (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid substituted by a hydroxy group at position 5 (5S) and an N-acetyl-L-cystein-S-yl group at position 6 (6R); it is a major bilary metabolite of cysteinyl leukotrienes. | N-acetylleukotriene E4 |
| n-acetyltyrosine | An N-acetyltyrosine in which the chiral centre has L configuration. | N-acetyl-L-tyrosine |
| n-acetyltyrosine, (dl)-isomer | An N-acetyl-amino acid that is tyrosine with an amine hydrogen substituted by an acetyl group. | N-acetyltyrosine |
| n-butyrylglycine | A N-acylglycine obtained by formal condensation of the carboxy group of butyric acid with the amino group of glycine. | butyrylglycine |
| n-hexanal | A saturated fatty aldehyde that is hexane in which one of the terminal methyl group has been mono-oxygenated to form the corresponding aldehyde. | hexanal |
| n-isobutyrylglycine | An N-acylglycine in which the acyl group is specified as isobutryl. | N-isobutyrylglycine |
| n-isovalerylglycine | An N-acylglycine in which the acyl group is specified as isovaleryl. | N-isovalerylglycine |
| n-myristoylglycine | An N-acylglycine in which the acyl group is specified as myristoyl (tetradecanoyl). | N-myristoylglycine |
| n(1)-methylnicotinamide | A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent. | 1-methylnicotinamide |
| niacin | A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group. | nicotinic acid |
| niacinamide | A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group. | nicotinamide |
| nicotinuric acid | An N-acylglycine having nicotinoyl as the acyl substituent. | N-nicotinoylglycine |
| nitrohexane | A primary nitroalkane that is hexane substituted by a nitro group at position 1. | 1-nitrohexane |
| prolyl-proline | A dipeptide formed from two L-proline residues. | Pro-Pro |
| pyridoxic acid | A methylpyridine that is 2-methylpyridine substituted by a hydroxy group at C-3, a carboxy group at C-4, and a hydroxymethyl group at C-5. It is the catabolic product of vitamin B6 and is excreted in the urine. | 4-pyridoxic acid |
| riboflavin | D-Ribitol in which the hydroxy group at position 5 is substituted by a 7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl moiety. It is a nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables, but the richest natural source is yeast. The free form occurs only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin-adenine dinucleotide. | riboflavin |
| s-adenosyl-3-methylthiopropylamine | The S-adenosyl derivative of methioninamine. It acts as the aminopropyl donor in the biosynthesis of the polyamines, spermidine and spermine. | S-adenosylmethioninamine |
| s-benzyl-n-acetyl-l-cysteine | The S-benzyl derivative of N-acetyl-L-cysteine. | N-acetyl-S-benzyl-L-cysteine |
| s-methylcysteine | A cysteine derivative that is L-cysteine in which the hydrogen attached to the sulfur is replaced by a methyl group. | S-methylcysteine zwitterion; S-methylcysteine |
| s-phenyl-n-acetylcysteine | The S-phenyl derivative of N-acetyl-L-cysteine. It is a urinary metabolite of benzene and used as a biomarker to assess benzene exposure. | N-acetyl-S-phenyl-L-cysteine |
| salicyl alcohol | A hydroxybenzyl alcohol that is phenol substituted by a hydroxymethyl group at C-2. | salicyl alcohol |
| salsolinol | A 1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol that has S-configuration. | (S)-salsolinol |
| testosterone-17-sulfate | A steroid sulfate that is testosterone substituted by a sulfoxy group at position 17. | testosterone sulfate |
| trigonelline | An iminium betaine that is the conjugate base of N-methylnicotinic acid, arising from deprotonation of the carboxy group. | N-methylnicotinate |
| tyramine o-sulfate | An aryl sulfate that is tyramine in which the phenolic hydrogen at position 4 has been replaced by a sulfo group. | sulfuric acid [4-(2-aminoethyl)phenyl] ester; tyramine sulfate zwitterion; tyramine sulfate |
| tyramine o-sulfate | A zwitterion obtained by transfer of a proton from the sulfate to the amino group of tyramine sulfate; major species at pH 7.3. | sulfuric acid [4-(2-aminoethyl)phenyl] ester; tyramine sulfate zwitterion; tyramine sulfate |
| ursocholic acid | A bile acid that is 5beta-cholan-24-oic acid bearing three hydroxy substituents at positions 3alpha, 7beta and 12alpha. | ursocholic acid |
| vitamin k 3 | A member of the class of 1,4-naphthoquinones that is 1,4-naphthoquinone which is substituted at position 2 by a methyl group. It is used as a nutritional supplement and for the treatment of hypoprothrombinemia. | menadione |
| yunaconitine | A diterpene alkaloid with formula C35H49NO11 that is isolated from several Aconitum species. | yunaconitine |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 26.1200 | 1 | 9 |
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 21.8659 | 1 | 5 |
| 67.9K protein | Vaccinia virus | Potency | 13.7572 | 2 | 5 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 49.4151 | 2 | 6 |
| acid sphingomyelinase | Homo sapiens (human) | Potency | 562.3410 | 1 | 1 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 42.3232 | 2 | 11 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 23.2644 | 1 | 12 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 20.5523 | 1 | 2 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 18.8541 | 1 | 2 |
| AR protein | Homo sapiens (human) | Potency | 26.6973 | 12 | 82 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 31.8276 | 3 | 27 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 13.7233 | 4 | 4 |
| Ataxin-2 | Homo sapiens (human) | Potency | 26.2167 | 2 | 7 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 0.7569 | 1 | 1 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 21.7954 | 2 | 9 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 3.9566 | 2 | 5 |
| BRCA1 | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 30.0469 | 1 | 3 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 76.9588 | 1 | 1 |
| caspase-1 isoform alpha precursor | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 81.5991 | 1 | 1 |
| caspase-3 | Homo sapiens (human) | Potency | 76.9588 | 1 | 1 |
| Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 81.5991 | 1 | 1 |
| Caspase-7 | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 35.4288 | 2 | 18 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 9.3265 | 2 | 11 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 21.9563 | 1 | 5 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 11.2113 | 1 | 3 |
| Chain A, Breast cancer type 1 susceptibility protein | Homo sapiens (human) | Potency | 7.9433 | 1 | 1 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 9.7199 | 2 | 3 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 39.8107 | 1 | 1 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 8.9360 | 2 | 7 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 68.1839 | 1 | 3 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 18.8102 | 1 | 6 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 10.7150 | 2 | 5 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 19.1011 | 1 | 5 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 8.9360 | 2 | 7 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 74.6729 | 1 | 6 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 9.7548 | 1 | 5 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 7.8017 | 1 | 5 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 13.9309 | 1 | 3 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 14.1826 | 1 | 3 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 11.2641 | 1 | 3 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 17.3480 | 2 | 12 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 7.0794 | 2 | 4 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 28.1236 | 1 | 12 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | Potency | 9.4494 | 1 | 2 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | Potency | 22.3872 | 1 | 1 |
| DNA polymerase beta | Homo sapiens (human) | Potency | 46.7960 | 1 | 2 |
| DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 41.0522 | 1 | 3 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 69.2292 | 1 | 5 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 22.3872 | 1 | 1 |
| endonuclease IV | Escherichia coli | Potency | 25.1189 | 1 | 1 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 29.0710 | 12 | 114 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 25.9771 | 3 | 33 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 24.5756 | 10 | 56 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 13.0072 | 1 | 8 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 19.3448 | 4 | 11 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 34.2333 | 4 | 17 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 31.7509 | 1 | 3 |
| fructose-bisphosphate aldolase A | Oryctolagus cuniculus (rabbit) | Potency | 6.3096 | 1 | 1 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| G | Vesicular stomatitis virus | Potency | 13.9309 | 1 | 3 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| GALC protein | Homo sapiens (human) | Potency | 0.7079 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 17.3480 | 1 | 6 |
| geminin | Homo sapiens (human) | Potency | 14.0501 | 2 | 10 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 22.2639 | 2 | 34 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 12.0514 | 2 | 4 |
| GLS protein | Homo sapiens (human) | Potency | 11.2947 | 1 | 2 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 18.3636 | 1 | 7 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 32.8297 | 5 | 21 |
| glucokinase regulatory protein | Homo sapiens (human) | Potency | 22.3872 | 1 | 1 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 25.5872 | 1 | 7 |
| glyceraldehyde-3-phosphate dehydrogenase isoform 1 | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 18.1696 | 1 | 2 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Homo sapiens (human) | Potency | 4.6451 | 2 | 2 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 30.2468 | 2 | 7 |
| hemoglobin subunit beta | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
| hexokinase-4 isoform 1 | Homo sapiens (human) | Potency | 22.3872 | 1 | 1 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 9.8391 | 2 | 17 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 24.3616 | 1 | 2 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 18.2920 | 2 | 12 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 71.8746 | 2 | 17 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 13.9309 | 1 | 3 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 34.5667 | 2 | 6 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 6.7541 | 2 | 10 |
| IDH1 | Homo sapiens (human) | Potency | 3.6626 | 1 | 1 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 13.9309 | 1 | 6 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 7.5870 | 1 | 4 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 9.5078 | 1 | 6 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 9.5078 | 1 | 6 |
| Interferon beta | Homo sapiens (human) | Potency | 16.3846 | 3 | 10 |
| interleukin 8 | Homo sapiens (human) | Potency | 59.5572 | 1 | 1 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 16.7840 | 3 | 8 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 22.3831 | 1 | 7 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 34.4108 | 3 | 11 |
| lysosomal alpha-glucosidase preproprotein | Homo sapiens (human) | Potency | 29.8911 | 2 | 4 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 78.1171 | 1 | 2 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 15.4884 | 2 | 13 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 15.4253 | 1 | 6 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 8.9072 | 2 | 2 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 7.5084 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 29.8911 | 1 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 29.8911 | 1 | 2 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 2.5119 | 1 | 2 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 5.1358 | 1 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 27.4349 | 4 | 38 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | Homo sapiens (human) | Potency | 44.6684 | 1 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 35.2349 | 2 | 10 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 54.4297 | 1 | 3 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 12.1036 | 2 | 6 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 34.9347 | 3 | 42 |
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | Potency | 25.1189 | 1 | 1 |
| P53 | Homo sapiens (human) | Potency | 2.5119 | 1 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 59.0442 | 1 | 3 |
| Parkin | Homo sapiens (human) | Potency | 14.3978 | 2 | 2 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 17.6654 | 2 | 3 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 16.9441 | 1 | 1 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 29.8494 | 5 | 26 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 23.5207 | 5 | 23 |
| phosphoglycerate kinase | Trypanosoma brucei brucei TREU927 | Potency | 9.9621 | 2 | 2 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 33.9594 | 1 | 4 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 11.2202 | 1 | 1 |
| polyprotein | Zika virus | Potency | 25.1189 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 8.8925 | 1 | 2 |
| PPM1D protein | Homo sapiens (human) | Potency | 17.8636 | 1 | 4 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 40.4212 | 2 | 20 |
| pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 50.1187 | 1 | 1 |
| progesterone receptor | Homo sapiens (human) | Potency | 33.3522 | 2 | 14 |
| pyruvate kinase | Leishmania mexicana mexicana | Potency | 12.5893 | 2 | 2 |
| pyruvate kinase PKM isoform a | Homo sapiens (human) | Potency | 15.8489 | 2 | 2 |
| pyruvate kinase PKM isoform b | Homo sapiens (human) | Potency | 25.1189 | 2 | 2 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 15.8314 | 2 | 26 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 8.2852 | 1 | 2 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 37.6858 | 1 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 28.9654 | 3 | 43 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 26.3568 | 4 | 35 |
| serine-protein kinase ATM isoform a | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 32.7968 | 3 | 15 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 32.7968 | 3 | 15 |
| Smad3 | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 23.1160 | 1 | 5 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 15.7067 | 1 | 5 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 9.5148 | 1 | 3 |
| TDP1 protein | Homo sapiens (human) | Potency | 18.6521 | 2 | 21 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 26.6514 | 1 | 2 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 13.9008 | 1 | 2 |
| Thrombopoietin | Homo sapiens (human) | Potency | 1.5849 | 2 | 2 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 39.2962 | 3 | 27 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 5.9289 | 1 | 3 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 39.5358 | 6 | 16 |
| thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 20.1238 | 2 | 6 |
| transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
| tumor necrosis factor | Homo sapiens (human) | Potency | 53.0804 | 1 | 1 |
| tyrosine-protein kinase Yes | Homo sapiens (human) | Potency | 30.7475 | 1 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 9.4494 | 1 | 2 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 11.2202 | 1 | 1 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 11.2202 | 1 | 1 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 42.8075 | 2 | 6 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 25.4968 | 2 | 10 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 16.6154 | 5 | 20 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 20.5367 | 1 | 3 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 25.5872 | 1 | 7 |
| WRN | Homo sapiens (human) | Potency | 28.1838 | 1 | 1 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | IC50 | 8.6815 | 2 | 2 |
| 10 kDa chaperonin | Escherichia coli | IC50 | 32.3750 | 2 | 4 |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 57.5000 | 1 | 2 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | Homo sapiens (human) | IC50 | 1.6300 | 1 | 2 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | IC50 | 8.4300 | 2 | 4 |
| 3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 4.0000 | 1 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | IC50 | 10.4690 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 10.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | Ki | 2.9910 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | IC50 | 14.9100 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 7.8060 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | IC50 | 14.9100 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | Ki | 7.8060 | 1 | 1 |
| 60 kDa chaperonin | Escherichia coli K-12 | IC50 | 250.0000 | 1 | 2 |
| 60 kDa chaperonin | Escherichia coli | IC50 | 32.3750 | 2 | 4 |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 57.5000 | 1 | 2 |
| 72 kDa type IV collagenase | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Acetylcholinesterase | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 1 |
| Acetylcholinesterase | Homo sapiens (human) | Ki | 92.8000 | 1 | 1 |
| Acetylcholinesterase | Bos taurus (cattle) | IC50 | 233.0000 | 1 | 1 |
| Adenosine receptor A1 | Homo sapiens (human) | IC50 | 19.9040 | 1 | 1 |
| Adenosine receptor A1 | Homo sapiens (human) | Ki | 11.6110 | 1 | 1 |
| Adenosine receptor A2a | Homo sapiens (human) | IC50 | 17.4420 | 1 | 1 |
| Adenosine receptor A2a | Homo sapiens (human) | Ki | 9.7920 | 1 | 1 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | Ki | 36.0000 | 1 | 1 |
| Aldehyde oxidase | Homo sapiens (human) | IC50 | 0.2700 | 1 | 2 |
| Aldehyde oxidase 1 | Macaca fascicularis (crab-eating macaque) | IC50 | 0.1100 | 1 | 1 |
| Aldehyde oxidase 1 | Mus musculus (house mouse) | IC50 | 0.1500 | 1 | 1 |
| Aldehyde oxidase 1 | Oryctolagus cuniculus (rabbit) | IC50 | 2.0000 | 1 | 1 |
| Aldehyde oxidase 1 | Cavia porcellus (domestic guinea pig) | Ki | 7.2300 | 1 | 1 |
| Aldehyde oxidase 1 | Rattus norvegicus (Norway rat) | IC50 | 0.1900 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | IC50 | 15.0000 | 1 | 2 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 1.3300 | 1 | 1 |
| Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Alpha-glucosidase MAL32 | Saccharomyces cerevisiae S288C | IC50 | 61.0000 | 1 | 2 |
| Alpha-mannosidase | Canavalia ensiformis (jack bean) | IC50 | 49.0000 | 1 | 1 |
| Alpha-synuclein | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | IC50 | 4.8771 | 6 | 7 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | Ki | 26.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Bos taurus (cattle) | IC50 | 95.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | IC50 | 40.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Bos taurus (cattle) | IC50 | 95.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | IC50 | 3.9333 | 3 | 3 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | Ki | 0.4000 | 1 | 1 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 56.4200 | 5 | 5 |
| Androgen receptor | Homo sapiens (human) | IC50 | 654.8500 | 1 | 2 |
| Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 62.9259 | 1 | 2 |
| Arginase | Leishmania amazonensis | IC50 | 55.0000 | 1 | 1 |
| Aromatase | Homo sapiens (human) | Ki | 111.5000 | 2 | 2 |
| Aryl hydrocarbon receptor | Homo sapiens (human) | IC50 | 0.0280 | 1 | 1 |
| Aurora kinase B | Homo sapiens (human) | IC50 | 4.0300 | 1 | 1 |
| Autoinducer 2-binding periplasmic protein LuxP | Vibrio harveyi | IC50 | 4.0000 | 1 | 1 |
| Beta-glucuronidase | Homo sapiens (human) | IC50 | 36.4700 | 1 | 1 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 7.0000 | 1 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 6.6500 | 2 | 4 |
| Calcium release-activated calcium channel protein 1 | Homo sapiens (human) | IC50 | 500.0000 | 2 | 2 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | IC50 | 50.7143 | 1 | 7 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 0.1459 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 9.5257 | 1 | 1 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 0.0250 | 1 | 1 |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | IC50 | 9.9330 | 1 | 1 |
| Carboxylic ester hydrolase | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 1 |
| Casein kinase II subunit alpha | Homo sapiens (human) | IC50 | 0.7000 | 2 | 2 |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | IC50 | 0.7000 | 2 | 2 |
| Casein kinase II subunit beta | Homo sapiens (human) | IC50 | 0.7000 | 2 | 2 |
| Cationic trypsin | Bos taurus (cattle) | IC50 | 105.9000 | 1 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | IC50 | 3.1000 | 1 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | Ki | 0.1320 | 1 | 1 |
| Chain A, Estrogen receptor 1 (alpha) | Homo sapiens (human) | IC50 | 0.0090 | 1 | 1 |
| Chain A, NAD-dependent deacetylase | Thermotoga maritima | IC50 | 1,000.0000 | 1 | 1 |
| Chain A, Nitrile Hydratase alpha subunit | Pseudonocardia thermophila | Ki | 1,300.0000 | 1 | 1 |
| Chain A, retinol dehydratase | Spodoptera frugiperda (fall armyworm) | Ki | 0.1100 | 1 | 1 |
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | IC50 | 57.6600 | 1 | 1 |
| Chain B, Nitrile Hydratase beta subunit | Pseudonocardia thermophila | Ki | 1,300.0000 | 1 | 1 |
| Cholesteryl ester transfer protein | Homo sapiens (human) | IC50 | 0.1400 | 1 | 1 |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Coagulation factor VII | Homo sapiens (human) | Ki | 8,000.0000 | 1 | 1 |
| Corticosteroid-binding globulin | Homo sapiens (human) | Ki | 6.2274 | 1 | 2 |
| Cruzipain | Trypanosoma cruzi | IC50 | 241.3500 | 2 | 2 |
| Cyclin homolog | Herpesvirus saimiri (strain 11) | IC50 | 29.3750 | 1 | 4 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | IC50 | 205.5000 | 2 | 2 |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | IC50 | 29.3750 | 1 | 4 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | IC50 | 33.7000 | 2 | 5 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | IC50 | 27.9000 | 2 | 5 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | IC50 | 33.7000 | 2 | 5 |
| Cytochrome P450 1A1 | Homo sapiens (human) | IC50 | 0.6320 | 1 | 1 |
| Cytochrome P450 1A1 | Homo sapiens (human) | Ki | 0.7500 | 1 | 1 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 95.9053 | 2 | 3 |
| Cytochrome P450 1B1 | Homo sapiens (human) | IC50 | 0.0470 | 1 | 1 |
| Cytochrome P450 1B1 | Homo sapiens (human) | Ki | 0.0430 | 1 | 1 |
| Cytochrome P450 2A5 | Mus musculus (house mouse) | IC50 | 53.7377 | 2 | 3 |
| Cytochrome P450 2A6 | Homo sapiens (human) | IC50 | 95.0363 | 2 | 3 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 0.1400 | 1 | 1 |
| Cytochrome P450 2C9 | Homo sapiens (human) | Ki | 6.0000 | 1 | 1 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Cytochrome P450 3A5 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | IC50 | 67.9900 | 1 | 1 |
| D-amino-acid oxidase | Homo sapiens (human) | IC50 | 1,125.0000 | 1 | 1 |
| D-aspartate oxidase | Homo sapiens (human) | IC50 | 2,778.0000 | 1 | 1 |
| D(1A) dopamine receptor | Homo sapiens (human) | Ki | 48.0000 | 1 | 2 |
| D(2) dopamine receptor | Homo sapiens (human) | Ki | 12.5000 | 2 | 2 |
| D(3) dopamine receptor | Homo sapiens (human) | Ki | 0.5000 | 1 | 1 |
| Death-associated protein kinase 1 | Homo sapiens (human) | IC50 | 54.0000 | 1 | 2 |
| Dihydroorotate dehydrogenase | Leishmania major | IC50 | 393.5035 | 1 | 2 |
| Dipeptidyl peptidase 3 | Homo sapiens (human) | IC50 | 34.7500 | 1 | 2 |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | IC50 | 44.3233 | 2 | 3 |
| Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | IC50 | 39.0000 | 1 | 1 |
| DNA (cytosine-5)-methyltransferase 1 | Homo sapiens (human) | IC50 | 30.0000 | 1 | 1 |
| DNA (cytosine-5)-methyltransferase 3-like | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| DNA (cytosine-5)-methyltransferase 3A | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | IC50 | 200.0000 | 2 | 2 |
| DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | IC50 | 200.0000 | 1 | 1 |
| Dopamine beta-hydroxylase | Bos taurus (cattle) | Ki | 700.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 4 | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Dual specificity protein phosphatase 1 | Mus musculus (house mouse) | IC50 | 24.0000 | 1 | 1 |
| Dual specificity protein phosphatase 6 | Rattus norvegicus (Norway rat) | IC50 | 20.5000 | 1 | 1 |
| E3 ubiquitin-protein ligase XIAP | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 20.0000 | 1 | 1 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 29.7169 | 7 | 13 |
| Estrogen receptor | Homo sapiens (human) | IC50 | 1.3477 | 23 | 25 |
| Estrogen receptor | Homo sapiens (human) | Ki | 0.2045 | 2 | 2 |
| Estrogen receptor beta | Homo sapiens (human) | IC50 | 2.0569 | 24 | 27 |
| Estrogen receptor beta | Homo sapiens (human) | Ki | 0.0123 | 2 | 2 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | IC50 | 3.3000 | 1 | 1 |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | IC50 | 250.0000 | 1 | 1 |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | IC50 | 29.3750 | 1 | 4 |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | IC50 | 205.5000 | 2 | 2 |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | IC50 | 41.0000 | 1 | 1 |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | IC50 | 41.0000 | 1 | 1 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Bos taurus (cattle) | IC50 | 22.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Bos taurus (cattle) | Ki | 0.0130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Bos taurus (cattle) | IC50 | 22.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Bos taurus (cattle) | IC50 | 22.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Bos taurus (cattle) | IC50 | 22.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Bos taurus (cattle) | IC50 | 22.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Bos taurus (cattle) | Ki | 0.0130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Bos taurus (cattle) | IC50 | 22.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | IC50 | 1.3670 | 1 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | Ki | 14.1000 | 2 | 2 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | IC50 | 3.5000 | 1 | 1 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | IC50 | 3.5000 | 1 | 1 |
| Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | IC50 | 29.3750 | 1 | 4 |
| Histone deacetylase 1 | Homo sapiens (human) | IC50 | 158.0000 | 2 | 2 |
| Histone deacetylase 1 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 11 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 2 | Homo sapiens (human) | IC50 | 206.0000 | 2 | 2 |
| Histone deacetylase 2 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 3 | Homo sapiens (human) | IC50 | 9.0000 | 1 | 1 |
| Histone deacetylase 3 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 4 | Homo sapiens (human) | IC50 | 2,000.0000 | 1 | 1 |
| Histone deacetylase 4 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 5 | Homo sapiens (human) | IC50 | 2,000.0000 | 1 | 1 |
| Histone deacetylase 5 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 6 | Homo sapiens (human) | IC50 | 2,000.0000 | 1 | 1 |
| Histone deacetylase 6 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 7 | Homo sapiens (human) | IC50 | 1,150.0000 | 2 | 2 |
| Histone deacetylase 7 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 8 | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Histone deacetylase 8 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone deacetylase 9 | Homo sapiens (human) | IC50 | 2,000.0000 | 1 | 1 |
| Histone deacetylase 9 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Hydroxycarboxylic acid receptor 2 | Homo sapiens (human) | IC50 | 4.3681 | 16 | 16 |
| Hydroxycarboxylic acid receptor 2 | Mus musculus (house mouse) | IC50 | 0.1400 | 3 | 3 |
| Hydroxycarboxylic acid receptor 2 | Homo sapiens (human) | Ki | 0.0787 | 3 | 3 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | IC50 | 0.8925 | 4 | 4 |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | IC50 | 2.5000 | 1 | 1 |
| Inositol polyphosphate multikinase | Homo sapiens (human) | IC50 | 4.4000 | 1 | 1 |
| Integrase | Human immunodeficiency virus 1 | IC50 | 40.7200 | 5 | 5 |
| Interstitial collagenase | Homo sapiens (human) | IC50 | 2.6350 | 1 | 2 |
| Kinesin-like protein KIF11 | Homo sapiens (human) | IC50 | 63.0000 | 1 | 1 |
| Lactoylglutathione lyase | Homo sapiens (human) | IC50 | 20.6000 | 1 | 1 |
| Lysine-specific demethylase 4E | Homo sapiens (human) | IC50 | 10,000.0000 | 1 | 1 |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | IC50 | 4.5500 | 2 | 2 |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | IC50 | 3.1600 | 3 | 3 |
| M-phase inducer phosphatase 3 | Homo sapiens (human) | IC50 | 18.9000 | 2 | 2 |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | IC50 | 6.5050 | 2 | 2 |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | Ki | 10.4000 | 1 | 1 |
| Matrilysin | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | IC50 | 32.9667 | 1 | 3 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | IC50 | 32.9667 | 1 | 3 |
| MO15-related protein kinase Pfmrk | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 93.0000 | 1 | 1 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 800.0000 | 1 | 1 |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | Ki | 2.4000 | 2 | 2 |
| Myeloperoxidase | Homo sapiens (human) | IC50 | 2.2400 | 1 | 1 |
| NAD-dependent histone deacetylase SIR2 | Saccharomyces cerevisiae S288C | IC50 | 50.0000 | 1 | 1 |
| NAD-dependent protein deacetylase | Schistosoma mansoni | IC50 | 221.5500 | 2 | 2 |
| NAD-dependent protein deacetylase HST2 | Saccharomyces cerevisiae S288C | IC50 | 91.0000 | 1 | 1 |
| NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | IC50 | 130.9500 | 12 | 12 |
| NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | IC50 | 28.2214 | 14 | 14 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Homo sapiens (human) | IC50 | 78.4571 | 7 | 7 |
| NAD-dependent protein deacetylase sirtuin-6 | Homo sapiens (human) | IC50 | 173.3500 | 4 | 4 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | IC50 | 58.2000 | 3 | 3 |
| NAD(+) hydrolase SARM1 | Homo sapiens (human) | IC50 | 43.8000 | 1 | 1 |
| NADPH oxidase 4 | Homo sapiens (human) | IC50 | 1.2000 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/USSR/90/1977(H1N1)) | IC50 | 63.7000 | 2 | 2 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | IC50 | 64.1571 | 4 | 7 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | Ki | 21.1000 | 1 | 1 |
| Nicotinamidase | Saccharomyces cerevisiae S288C | Ki | 2,000.0000 | 1 | 1 |
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | IC50 | 67.5410 | 1 | 1 |
| Ornithine decarboxylase | Homo sapiens (human) | IC50 | 26.0000 | 1 | 1 |
| Oxysterols receptor LXR-alpha | Homo sapiens (human) | IC50 | 46.0000 | 3 | 4 |
| Oxysterols receptor LXR-beta | Homo sapiens (human) | IC50 | 48.0000 | 2 | 3 |
| Pancreatic triacylglycerol lipase | Sus scrofa (pig) | IC50 | 90.0000 | 2 | 3 |
| perilipin-1 | Homo sapiens (human) | IC50 | 7.8950 | 1 | 1 |
| perilipin-5 | Homo sapiens (human) | IC50 | 9.4680 | 1 | 1 |
| Phenylethanolamine N-methyltransferase | Bos taurus (cattle) | IC50 | 314.0000 | 1 | 1 |
| Phenylethanolamine N-methyltransferase | Bos taurus (cattle) | Ki | 1,250.0000 | 1 | 1 |
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | IC50 | 187.0070 | 6 | 7 |
| Poly [ADP-ribose] polymerase 2 | Mus musculus (house mouse) | IC50 | 129.5245 | 1 | 2 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | Ki | 136.0000 | 1 | 1 |
| Polyphenol oxidase 1 | Agaricus bisporus | IC50 | 10.5000 | 1 | 1 |
| Polyphenol oxidase 2 | Agaricus bisporus | IC50 | 423.8000 | 3 | 3 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | IC50 | 2.7000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | IC50 | 55.0000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | IC50 | 5.6165 | 2 | 2 |
| Prolyl endopeptidase | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 66.3000 | 3 | 3 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Proteasome subunit beta type-5 | Homo sapiens (human) | IC50 | 23.9400 | 4 | 4 |
| Protein E6 | Human papillomavirus 16 | IC50 | 20.0000 | 1 | 1 |
| Protein kinase C alpha type | Homo sapiens (human) | IC50 | 50.8000 | 3 | 9 |
| Protein mono-ADP-ribosyltransferase PARP15 | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Protein orai-2 | Homo sapiens (human) | IC50 | 500.0000 | 2 | 2 |
| Protein orai-3 | Homo sapiens (human) | IC50 | 500.0000 | 2 | 2 |
| Protein-glutamine gamma-glutamyltransferase 2 | Homo sapiens (human) | IC50 | 2.2000 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | IC50 | 61.6667 | 3 | 3 |
| Proton-coupled amino acid transporter 1 | Homo sapiens (human) | Ki | 2,200.0000 | 1 | 1 |
| Pyruvate kinase PKM | Homo sapiens (human) | IC50 | 150.0000 | 1 | 1 |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | IC50 | 44.4900 | 1 | 1 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | IC50 | 70.0000 | 1 | 1 |
| Receptor protein-tyrosine kinase | Homo sapiens (human) | IC50 | 2.2000 | 1 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | IC50 | 2.3200 | 1 | 1 |
| Receptor-type tyrosine-protein phosphatase eta | Homo sapiens (human) | IC50 | 2.2000 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 7.9600 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | IC50 | 7.9600 | 1 | 1 |
| Riboflavin-binding protein | Gallus gallus (chicken) | Ki | 0.3500 | 1 | 1 |
| Secreted chorismate mutase | Mycobacterium tuberculosis H37Rv | IC50 | 11.6000 | 1 | 1 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | IC50 | 1.3000 | 1 | 1 |
| Short transient receptor potential channel 5 | Homo sapiens (human) | IC50 | 3.9000 | 1 | 1 |
| Sialidase | Clostridium perfringens | IC50 | 10.0250 | 2 | 2 |
| Sialidase-2 | Homo sapiens (human) | IC50 | 305.0000 | 1 | 2 |
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | IC50 | 24.8000 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | Mus musculus (house mouse) | IC50 | 501.1870 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | Mus musculus (house mouse) | IC50 | 25.7040 | 1 | 1 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | IC50 | 16.9180 | 1 | 1 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | Ki | 13.4420 | 1 | 1 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | IC50 | 0.3950 | 1 | 1 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | IC50 | 800.0000 | 1 | 1 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | Ki | 1,200.0000 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | IC50 | 4.0000 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | Ki | 7.0000 | 3 | 3 |
| Solute carrier family 2, facilitated glucose transporter member 4 | Mus musculus (house mouse) | IC50 | 20.0000 | 1 | 1 |
| Solute carrier family 22 member 20 | Mus musculus (house mouse) | Ki | 81.6416 | 1 | 2 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | Ki | 98.0000 | 1 | 1 |
| Solute carrier family 22 member 6 | Mus musculus (house mouse) | Ki | 3,483.6850 | 1 | 2 |
| Solute carrier organic anion transporter family member 1A1 | Rattus norvegicus (Norway rat) | Ki | 10.6000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | IC50 | 9.1201 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | Ki | 5.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | IC50 | 3.8904 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | Ki | 2.9600 | 1 | 1 |
| Steroid hormone receptor ERR1 | Homo sapiens (human) | IC50 | 4.8250 | 2 | 2 |
| Steroid hormone receptor ERR2 | Homo sapiens (human) | IC50 | 0.3950 | 1 | 1 |
| Stromelysin-1 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Substance-K receptor | Cavia porcellus (domestic guinea pig) | IC50 | 67.8500 | 1 | 2 |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | IC50 | 327.1400 | 2 | 5 |
| Succinate-semialdehyde dehydrogenase, mitochondrial | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | IC50 | 30.3000 | 1 | 1 |
| Thiopurine S-methyltransferase | Homo sapiens (human) | IC50 | 199.5260 | 1 | 1 |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | IC50 | 4.9000 | 1 | 2 |
| Thromboxane-A synthase | Homo sapiens (human) | IC50 | 7.7200 | 1 | 1 |
| Tissue alpha-L-fucosidase | Bos taurus (cattle) | IC50 | 54.0000 | 1 | 1 |
| Tissue factor | Homo sapiens (human) | Ki | 8,000.0000 | 1 | 1 |
| Toll-like receptor 2 | Mus musculus (house mouse) | IC50 | 53.8000 | 1 | 1 |
| Transthyretin | Homo sapiens (human) | IC50 | 7.8000 | 1 | 1 |
| Triosephosphate isomerase | Oryctolagus cuniculus (rabbit) | Ki | 123.0000 | 1 | 1 |
| Trypanothione reductase | Trypanosoma cruzi | IC50 | 55.0000 | 2 | 2 |
| Tyrosinase | Homo sapiens (human) | IC50 | 128.7033 | 3 | 3 |
| Tyrosinase | Mus musculus (house mouse) | IC50 | 500.0000 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | IC50 | 41.6667 | 3 | 9 |
| Tyrosine-protein kinase ABL2 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | IC50 | 50.7143 | 1 | 7 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | IC50 | 58.1800 | 1 | 1 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | IC50 | 2.2000 | 1 | 1 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | IC50 | 39.0000 | 1 | 1 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | Ki | 6.7700 | 1 | 1 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L1 | Homo sapiens (human) | IC50 | 290.0000 | 1 | 1 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L1 | Mus musculus (house mouse) | IC50 | 180.5000 | 1 | 2 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L3 | Homo sapiens (human) | IC50 | 71.0000 | 2 | 2 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L3 | Mus musculus (house mouse) | IC50 | 180.5000 | 1 | 2 |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | IC50 | 1.7300 | 1 | 1 |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | IC50 | 437.9475 | 4 | 4 |